Agile Therapeutics, Inc.
Charter Amendment in a 8-K on 01/10/2022   Download
SEC Document
SEC Filing
EX-3.1 3 tm222388d2_ex3-1.htm EXHIBIT 3.1

 

Exhibit 3.1

 

  State of Delaware
Secretary of State
Division of Corporations
Delivered 12:00 PM 01/07/2022
FILED 12:00 PM 0l/07/2022
SR 20220059027 - File Number 2829324

 

CERTIFICATE OF AMENDMENT 

TO 

AMENDED AND RESTATED

 

CERTIFICATE OF INCORPORATION 

OF 

AGILE THERAPEUTICS, INC.

 

AGILE THERAPEUTICS, INC., a corporation organized and existing under the General Corporation Law of the State of Delaware (the "Corporation"), does hereby certify as follows:

 

FIRST: The name of the Corporation is Agile Therapeutics, Inc. The Amended and Restated Certificate of Incorporation was originally filed with the Secretary of State of the State of Delaware (the "Secretary of State'') on May 29, 2014 (the "Certificate of lncorporation").

 

SECOND: The first sentence of Article IV, Section A, of the Certificate of Incorporation is hereby amended and restated in its entirety as follows

 

"The total number of shares of stock which the Corporation shall have authority to issue is 310,000,000, divided into two classes: 10,000,000 shares of Preferred Stock, par value $0.0001 per share (hereinafter referred to as "Preferred Stock"); and 300,000,000 shares of Common Stock, par value $0.0001 per share (hereinafter referred to as "Common Stock")."

 

THIRD: The stockholders of the Corporation have duly approved the foregoing amendment in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly adopted and executed in its corporate name and on its behalf by its duly authorized officer as of the 7th day of January, 2022.

 

 AGILE THERAPEUTICS, INC.

 

  By: /s/ ALFRED ALTOMARI
  Name: ALFRED ALTOMARI
  Title: President and Chief Executive Officer